- Home
- HVT vs BCYC Comparison
HVT vs BCYC Comparison
Compare HVT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HVT
- BCYC
- Stock Information
- Founded
- HVT 1885
- BCYC 2009
- Country
- HVT United States
- BCYC United Kingdom
- Employees
- HVT N/A
- BCYC N/A
- Industry
- HVT Other Specialty Stores
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- HVT Consumer Discretionary
- BCYC Health Care
- Exchange
- HVT Nasdaq
- BCYC Nasdaq
- Market Cap
- HVT 377.1M
- BCYC 438.4M
- IPO Year
- HVT N/A
- BCYC 2019
- Fundamental
- Price
- HVT $24.10
- BCYC $6.86
- Analyst Decision
- HVT
- BCYC Buy
- Analyst Count
- HVT 0
- BCYC 11
- Target Price
- HVT N/A
- BCYC $18.73
- AVG Volume (30 Days)
- HVT 130.5K
- BCYC 392.5K
- Earning Date
- HVT 10-29-2025
- BCYC 10-30-2025
- Dividend Yield
- HVT 5.31%
- BCYC N/A
- EPS Growth
- HVT N/A
- BCYC N/A
- EPS
- HVT 1.17
- BCYC N/A
- Revenue
- HVT $741,429,000.00
- BCYC $28,339,000.00
- Revenue This Year
- HVT $5.43
- BCYC N/A
- Revenue Next Year
- HVT $8.12
- BCYC N/A
- P/E Ratio
- HVT $20.58
- BCYC N/A
- Revenue Growth
- HVT N/A
- BCYC N/A
- 52 Week Low
- HVT $17.01
- BCYC $6.03
- 52 Week High
- HVT $24.91
- BCYC $21.50
- Technical
- Relative Strength Index (RSI)
- HVT 67.97
- BCYC 48.60
- Support Level
- HVT $22.25
- BCYC $6.03
- Resistance Level
- HVT $23.37
- BCYC $6.75
- Average True Range (ATR)
- HVT 0.66
- BCYC 0.41
- MACD
- HVT 0.12
- BCYC 0.04
- Stochastic Oscillator
- HVT 97.81
- BCYC 91.49
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.